1032767-70-6

Basic information

• Product Name: tert-butyl (S)-6-tert-butoxycarbonylamino-2-{3-[(R)-1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-ureido}-hexanoate
• Synonyms: tert-butyl (S)-6-tert-butoxycarbonylamino-2-{3-[(R)-1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-ureido}-hexanoate
• CAS NO: 1032767-70-6
• Molecular Weight: 562.75
• Mol File: 1032767-70-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl (S)-6-tert-butoxycarbonylamino-2-{3-[(R)-1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-ureido}-hexanoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (S)-6-tert-butoxycarbonylamino-2-{3-[(R)-1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-ureido}-hexanoate(1032767-70-6)
• EPA Substance Registry System: tert-butyl (S)-6-tert-butoxycarbonylamino-2-{3-[(R)-1-(3-methyl-butylcarbamoyl)-2-phenyl-ethyl]-ureido}-hexanoate(1032767-70-6)

Safety Data

• Hazardous Substances Data: 1032767-70-6(Hazardous Substances Data)

Upstream product

• 13288-57-8 1,1-dimethylethyl N₆-{[(1,1-dimethylethyl)oxy]carbonyl}-L-lysinate hydrochloride 
• 148528-72-7 D-phenylalanine isopentylamide 
• 530-62-1 1,1'-carbonyldiimidazole 

Relevant articles and documents

UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa

The invention relates to compounds of the formula I as defined herein, which are inhibitors of activated thrombin-activatable fibrinolysis inhibitor. The compounds of the formula I are suitable for manufacturing medicaments for the prophylaxis, secondary prevention and therapy of one or more disorders which are associated with thromboses, embolisms, hypercoagulability or fibrotic changes.